Subretinal injection of human adult stem cells yields favorable results in atrophic AMD

MIAMI — Patients who experience vision loss due to geographic atrophy may respond favorably to a subretinal injection of human adult stem cell therapy, a speaker said here.Allen C. Ho, MD, OSN Retina/Vitreous Board Member, said at Angiogenesis, Exudation, and Degeneration 2013 that stem cell therapy for atrophic age-related macular degeneration holds a promising future in ophthalmology.

Full Story →